CSBR Earnings
Latest Revenue15.2M
Latest Net Income-426000
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q1 2027 | -$0.03 | 15.2M | -426000 | -8.0% | -50.0% |
| Q4 2026 | -$0.05 | 13.8M | -667000 | -8.0% | -350.0% |
| Q4 2026 | -$0.05 | 13.8M | -667000 | -8.0% | -350.0% |
| Q3 2026 | -$0.02 | 16.6M | -279000 | +18.3% | +33.3% |
| Q3 2026 | -$0.02 | 16.6M | -279000 | +18.3% | +33.3% |
| Q2 2026 | $0.02 | 15.0M | 237.0K | +21.7% | +115.4% |
| Q2 2026 | $0.02 | 15.0M | 237.0K | -11.8% | -93.9% |
| Q1 2026 | -$0.03 | 14.0M | -466000 | +3.8% | -160.0% |
| Q1 2026 | -$0.03 | 14.0M | -466000 | — | — |
| Q4 2025 | -$0.13 | 12.4M | -1835000 | — | — |
| Q3 2025 | $0.33 | 17.0M | 4.5M | — | — |
| Q2 2025 | $0.05 | 13.5M | 728.0K | — | — |
Champions Oncology (CSBR) — Earnings